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SUMMARY  
Mitochondria maintain cellular homeostasis by coordinating ATP synthesis 
with metabolic activity, redox signaling, and apoptosis. Excessive levels of  
mitochondria-derived  reactive  oxygen  species  (ROS) 
 promote mitochondrial dysfunction and human diseases including 
cancer, neurodegeneration, and numerous metabolic disorders. However, the 
molecular basis for the harmful effects of excessive ROS formation is largely 
unknown. Intriguingly, we identified a new link between mitochondrial stress 
and ubiquitin-dependent proteolysis supporting cellular surveillance both in 
Caenorhabditis elegans and humans. Worms defective in respiration with 
elevated ROS levels are limited in turnover of a GFP-based substrate protein, 
demonstrating that mitochondrial stress affects the ubiquitin/proteasome 
system (UPS). Moreover, we observed similar proteolytic defects for different 
human metabolic diseases caused by mitochondrial failure. Together, these 
results identify a conserved link between mitochondrial metabolism and 
ubiquitin-dependent proteostasis, suggesting that reduced UPS activity 
during pathological conditions might potentiate disease progression.  
  
INTRODUCTION  
In eukaryotic cells mitochondria are central for various cellular processes including 
the generation of energy and the orchestration of anabolic and catabolic 
metabolism. Defects in mitochondrial homeostasis are closely linked to the 
development of human pathologies such as cancer, neurodegenerative diseases, 
type 2 diabetes and additional metabolic disorders (Wallace, 2005). While limited 
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amounts of ROS appear to exert health-promoting functions in diverse species 
(Ristow and Zarse, 2010), mitochondrial dysfunction and protein damage are 
mainly caused by excessive formation of ROS, which are byproducts of oxidative 
phosphorylation and energy production in form of ATP (Livnat-Levanon and 
Glickman, 2010; Pagliarini et al., 2008; Tatsuta, 2009). Oxidative stress provoked 
by respiration defects usually results in misfolding and aggregation of 
mitochondrial proteins and finally leads to irreversible damage of mitochondria 
(Esposito et al., 1999; Tatsuta, 2009). Additionally, metabolic failure in catabolic 
pathways can cause accumulation of intermediates and biochemical stress within 
mitochondria (Sack and Finkel, 2012).  
 Several quality control mechanisms have evolved to maintain functional 
mitochondria by eliminating damaged proteins or even the entire organelle. 
Besides autophagic consumption of damaged mitochondria (called mitophagy), 
(Ashrafi and Schwarz, 2013; Kubli and Gustafsson, 2012) these mechanisms 
include different proteolytic quality control pathways in all mitochondrial 
compartments. One major system for protein degradation within mitochondria is 
based on the AAA-proteases Oma1 and Yme1, which mediate the turnover of inner 
mitochondrial membrane (IMM) proteins (Tatsuta, 2009; Tatsuta and Langer, 
2009). The mitochondrial matrix harbors Lon and ClpP proteases, the latter is also 
discussed to be part of the mitochondrial unfolded protein response (UPRmt) 
(Matsushima and Kaguni, 2012). In contrast, selective turnover of at least some 
outer mitochondrial membrane proteins involves the UPS (LivnatLevanon and 
Glickman, 2010). Damaged proteins are marked with a polyubiquitin chain formed 
by ubiquitin-activating enzymes (E1), ubiquitinconjugating enzymes (E2), and 
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ubiquitin protein ligases (E3) (Kerscher et al., 2006; Komander and Rape, 2012; 
Kuhlbrodt et al., 2005). In fact, the recently described mitochondria-associated 
degradation (MAD) pathway involves the ubiquitin-selective chaperone Cdc48/p97 
in retrotranslocation of substrates from mitochondria for degradation by the 26S 
proteasome (Cohen et al., 2008; Franz et al., 2013; Heo et al., 2010; Karbowski 
and Youle, 2011; Taylor and Rutter, 2011). Upon high oxidative stress conditions, 
Cdc48 and UPS components including the E3 ligase HUWE1 are recruited to the 
mitochondrial outer membrane (Cohen et al., 2008; Heo et al., 2010; Taylor and 
Rutter, 2011). This network of different mitochondrial quality control systems is 
transcriptionally controlled by the UPRmt (Haynes and Ron, 2010; Pellegrino et al., 
2013; Zhao et al., 2002) however, the coordination between mitochondrial and 
cellular proteostasis pathways has not been addressed so far.  
 Here, we identified a novel link between mitochondrial metabolism and the UPS, 
which supports cellular surveillance. Inactivation of gene products engaged in 
oxidative phosphorylation or mitochondrial metabolism results in stabilization of a 
GFP-based substrate in the worm intestine, suggesting a yet unknown influence 
emanating from mitochondria on ubiquitin-dependent proteolysis in the cytosol. 
These defects in degradation are linked to enhanced oxidative stress since 
substrate stabilization can be suppressed by antioxidants. Moreover, an increase 
in ROS levels accumulating with acute depletion of mitochondrial gene transcripts 
strictly correlates with reduced UPS activity. The failure in ubiquitindependent 
proteolysis appears to be downstream of the ubiquitin conjugation process 
because increased proteasomal capacity is able to restore substrate turnover. 
Since we show similar results in patient cell lines defective in mitochondrial 
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metabolism, our findings support the idea that ROS-induced changes in ubiquitin-
mediated proteolysis contribute to human mitochondrial pathology and might foster 
disease progression.  
  
  
  
  
  
  
  
  
  
  
  
RESULTS   
A Genetic Screen for Proteolytic Defects Identifies the E3 Ligase HECD-1  The 
UPS is central for the elimination of damaged proteins and the maintenance of 
cellular proteostasis; however, the physiological requirements for tissue function 
and organismal growth remained unclear. To identify new factors regulating protein 
turnover in multicellular organisms, we used a well established in vivo degradation 
assay that monitors even minor defects in proteostasis and stress response in C. 
elegans (Segref and Hoppe, 2012; Segref et al., 2011). This system is based on 
short-lived ubiquitin-fusion proteins (called UFD substrates), which was 
extensively applied to define fundamental mechanisms and important, 
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physiologically relevant degradation pathways of the UPS in single celled studies 
(Johnson et al., 1995; Koegl et al., 1999; Richly et al., 2005;  
Seufert and Jentsch, 1992). Worms expressing a GFP-based UFD substrate UbV-
GFP (Ub-GFP) under control of the ubiquitous sur-5 promoter show no green 
fluorescence due to low steady state levels of the fusion protein enforced by  
polyubiquitylation of the N-terminal ubiquitin moiety and subsequent rapid 
proteasomal degradation. We used this reporter strain to monitor proteolytic 
defects in a forward genetic screen, where similar co-expression of the stable 
mCherry protein served as control to exclude transcriptional and translational 
changes (Figure 1A). 10 000 worms were mutagenized using ethyl 
methanesulfonate (EMS) and screened in the F2 generation for viable, 
GFPpositive mutants with increased Ub-GFP substrate levels (Figure 1A). Only 
nonlethal mutations were examined in our study, precluding disruption of essential 
functions such as proteasomal integrity. Among others, we first focused on four 
mutants with very strong and similar stabilization of GFP for further 
characterization (hecd-1(hh2-4, hh9), Table S1). A non-complementation analysis 
revealed that these mutants were not able to complement each other (Table S2) 
and whole genome sequencing (WGS) of three mutants revealed independent stop 
mutations in the same gene called hecd-1 (Supplemental Figure S1A). 
Additionally, a hecd-1(tm2371) deletion mutant caused Ub-GFP stabilization in all 
tissues, which confirmed the phenotype of the hecd-1 mutants identified in our 
screen (Figures 1B and 1C). Moreover, these mutants did not complement the 
hecd-1 deletion mutant (Table S2). Thus, our forward genetic screen identified 
HECD-1 as an important factor for ubiquitin-dependent substrate turnover. In fact, 
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HECD-1 is a HECT domain-containing E3 ligase related to human HECtD1 and 
HUWE1 (Leboucher et al., 2012; Shaye and  
Greenwald, 2011).  
  
Loss of Functional IVD-1 and ACS-19 Limits Ubiquitin-dependent Protein 
Degradation  
In addition, our screen identified two other mutants with strong stabilization of the  
Ub-GFP substrate, which are independent of hecd-1 defects (ivd-1(hh6), 
acs19(hh5), Table S1, Table S2). SNP mapping and WGS placed the mutations 
into a 3.96 and 3.6 Mbp region on chromosomes III and IV, respectively 
(Supplemental Figures S1B and S1C). RNAi against potential candidates revealed 
that ivd-1(RNAi) and acs-19(RNAi) generate similar GFP stabilization in the 
intestine compared to the ivd-1(hh6) and acs-19(hh5) mutations found in the 
screen (Figure 2A-C). The mutation in ivd-1(hh6) causes a G to A splice donor 
mutation of the second intron, creating an aberrantly spliced mRNA (Supplemental 
Figure S1C). Consequently, sequencing of the ivd-1(hh6) cDNA confirmed a 
deletion of 45 nucleotides of the second exon, causing an in frame deletion of 15 
amino acids that are highly conserved between different species including human 
IVD (Supplemental Figure S1D). In the acs-19(hh5) mutant the conserved glycine 
residue 311 (G311) is exchanged against arginine (R) (Supplemental Figures S1B 
and S1E). Thus, loss of important residues in the ivd-1 or acs-19 mutants together 
with the recessive nature in genetic complementation studies suggest reduced 
protein functions. Accordingly, transgenic expression of the respective wild-type 
genes could rescue the proteolytic defect of ivd-1(hh6) and acs-19(hh5) worms 
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(Figure 2D, Supplemental Figure S2A-C), indicating that IVD-1 and ACS-19 activity 
are linked to ubiquitindependent protein turnover.  
IVD-1 is the orthologue of human isovaleryl-CoA dehydrogenase (IVD) 
(Mohsen et al., 2001), a mitochondrial enzyme with a defined role in the leucine 
catabolism pathway. During leucine degradation IVD catalyzes the conversion of 
isovaleryl-CoA into 3-methylcrotonyl-CoA (Supplemental Figure S2E) (Vockley 
and Ensenauer, 2006). We therefore asked if this particular step during leucine 
degradation might be important for turnover of the Ub-GFP substrate. RNAi against 
predicted orthologues genes of human BCKDHB and MCCC1 expected to act 
upstream or downstream, respectively of ivd-1 (Marcotte et al., 2000; Shaye and 
Greenwald, 2011), revealed an accumulation of Ub-GFP (Figure 2E, Supplemental 
Figure S2E), indicating that perturbance of the mitochondrial leucine degradation 
pathway per se affects ubiquitin-dependent protein turnover.  
ACS-19 is defined as actetyl-CoA synthetase the predicted orthologue to human  
ACSS2, a cytosolic enzyme that catalyses the conversion of acetate to acetylCOA 
required for fatty acid cycle in the mitochondrial matrix (Shaye and Greenwald, 
2011; Starai and Escalante-Semerena, 2004). In this regard it is interesting that 
the human HECT E3 ligase HUWE1 is also required for mitochondrial integrity 
because it targets mitofusin 2 for proteasomal degradation (Leboucher et al., 
2012). Therefore, it is very likely that HECD-1 identified in our screen is also 
involved in mitochondrial maintenance in worms. These data indicate that our 
screen for UPS activity defects predominantly identified mutants with diminished 
mitochondrial function.   
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Increased Proteasomal Activity Restores Substrate Turnover in ivd-1 and 
acs-19 Mutants  
To address the correlation between mitochondrial defects and decreased UPS 
activity we further evaluated the role of ivd-1, acs-19, and hecd-1 in 
ubiquitindependent protein turnover. Importantly, RNAi-mediated depletion of ivd-
1, acs19, and hecd-1 had no effect on the amount of K29,48RUb-GFP, a stable 
version of the substrate that cannot be polyubiquitylated, or of GFP alone 
(Supplemental Figure S2D). In contrast to loss of the E3 ligase HECD-1, the UFD 
substrate accumulates as polyubiquitylated forms in worms lacking IVD-1 or ACS-
19 (Figure 2F). This comparison confirmed that the effects of ivd-1, acs-19, and 
hecd-1 on steady state levels of Ub-GFP were due to diminished UPS function. In 
contrast to proteolysis of Ub-GFP in the cytosol, ER-associated protein 
degradation (ERAD) is not affected (Figure 3A). The ERAD substrate  
CPLW32A,Y35A  (Miedel et al., 2012) is only stabilized upon depletion of the Hrd3 
ligase homolog sel-1 (Grant and Greenwald, 1997), suggesting that IVD-1, ACS19, 
and HECD-1 do not participate in ERAD (Figure 3A). Indeed, the ERchaperone 
hsp-4 was also not induced after ivd-1, acs-19, or hecd-1 RNAi (Supplemental 
Figure S3A). The expression level of HSP-4 directly monitors defects in 
degradation of misfolded proteins accumulating in the ER lumen (Urano et al., 
2002). It would thus appear that IVD-1, ACS-19 and HECD-1 are not relevant for 
ER function. To investigate whether the mutants have an overall defect in protein 
turnover, we analyzed the levels of polyubiquitylated substrates and found them to 
be unchanged compared to wild-type worms (Figure 3B). This is consistent with 
    9 
the fact that these mutants are viable, whereas severe defects in the UPS induced 
by co-depletion of cdc-48.1 and cdc-48.2 lead to strong stabilization of 
polyubiquitylated substrates and lethality (Figure 3B) (Mouysset et al., 2008).   
Since IVD-1, ACS-19, and HECD-1 seem to be linked to mitochondrial 
function, one explanation for the reduction in UPS activity could be a decrease in 
ATP production, which would affect E1-dependent ubiquitin activation and 
proteasomal degradation. However, measurement of the ATP levels in the ivd-1, 
acs-19, and hecd-1 mutants revealed no decrease in the general ATP levels 
(Figure 3C). Thus, the defects in ubiquitin-dependent protein turnover are not due 
to changes in ATP availability. Similarly, the function of the 20S proteasome core 
particle is not reduced, as revealed by measurements of chymotrypsin-, trypsin-, 
and caspase-like activities (Figure 3D). We therefore examined if overexpression 
of the rpn-6 subunit, a component of the 19S lid complex that was previously shown 
to increase assembly and activity of the 26S proteasome could suppress the 
degradation defects of our mutants (Vilchez et al., 2012a; Vilchez et al., 2012b). 
Interestingly, overexpression of rpn-6 could indeed suppress the degradation 
defects of ivd-1 and acs-19 but not hecd-1 RNAi depleted worms (Figure 3E). This 
is consistent with the proposed role of HECD-1 acting as an E3 ligase in substrate 
recognition and suggests that the defects seen upon ivd-1 and acs-19 inactivation 
occur downstream of substrate  
recognition.  
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Enhanced Oxidative Stress Correlates with Impaired UPS Activity in Worms 
Lacking IVD-1, ACS-19, or HECD-1  
To evaluate the induction of stress responses, we analyzed the levels of heat shock 
protein 70 (hsp70) homologs in the ivd-1, acs-19, and hecd-1 mutants. Hsp-70 
supports protein folding in the cytosol, whereas HSP-6 facilitates mitochondrial 
import, biogenesis, and energy generation (Kimura et al., 2007).  
However, we could not detect any increase in cytosolic HSP-70 or mitochondrial 
HSP-6 levels (Supplemental Figure S3B and S3C). Therefore, we depleted key 
regulators of general stress pathways such as SKN-1, DAF-16, or HIF-1 by RNAi 
and examined proteolytic defects (Figure 4A) (An and Blackwell, 2003; Mehta et 
al., 2009; Ogg et al., 1997; Pickering et al., 2012). Interestingly, only down 
regulation of skn-1 revealed a strong stabilization of the Ub-GFP substrate. Since  
SKN-1 is the major transcription factor acting upon oxidative stress (An and 
Blackwell, 2003; Pickering et al., 2012), we examined whether the oxidative stress 
response is induced in worms lacking IVD-1, ACS-19, and HECD-1. Indeed, ivd-1, 
acs-19, and hecd-1 RNAi revealed an increase in the amount of the Glutathione S 
transferase GST-4, which expression is under tight control of  
SKN-1 and thus reflecting enhanced oxidative stress (Figure 4B) (Kahn et al., 
2008).  Accordingly, acute depletion of ivd-1 or acs-19 by RNAi revealed a transient 
increase in ROS production (Figure 4C) whereas constitutive ivd-1 and acs-19 
mutants exhibit reduced ROS levels in the steady-state (Supplemental Figure 
S3D). We reasoned that ivd-1 and acs-19 mutants might have adjusted to an initial 
accumulation of ROS due a process called mitohormesis, which was also reported 
for impaired insulin signaling by the DAF-2 receptor (Zarse et al., 2012). In further 
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support of an adaptive response mechanism, the ivd-1 and acs19 mutants 
exhibited reduced sensitivity upon treatment with antimycin A  
(Supplemental Figure S3E), which is a drug known to increase mitochondrial ROS 
production (Chen et al., 2003; Turrens, 1997). Conversely, hecd-1 mutant animals 
are more sensitive to antimycin A (Supplemental Figure S3E), consistent with the 
fact that worms lack a transient ROS increase after exposure to hecd-1 RNAi (not 
shown) but mutant hecd-1 rather show increased ROS levels in the steady-state 
(Supplemental Figure S3D). Importantly, the increased ROS level caused by ivd-1 
and acs-19 depletion or antimycin A treatment can be efficiently reduced by 
addition of the antioxidant N-acetyl cysteine (NAC) (Figure 4D). Therefore, we 
wondered whether the observed changes in ROS strictly correlate with reduced 
UPS activity. Indeed, similar to the elevated ROS level NAC also attenuated the 
protein turnover defects in ivd-1, acs-19, and hecd-1 mutants (Figure 4E), 
suggesting a general link between oxidative stress response in mitochondria and 
ubiquitin-dependent proteolysis in the cytosol.    
  
Inhibition of Oxidative Phosphorylation Affects Ubiquitin-Dependent 
Degradation  
Since our observations link ROS production with ubiquitin-dependent protein 
turnover defects, we next wondered whether mitochondrial dysfunction might be 
the underlying cause or contributes to this inhibition. Therefore we analyzed the 
stabilization of the Ub-GFP substrate upon RNAi depletion of critical components 
important for oxidative phosphorylation. Indeed, inhibition of respiratory chain 
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function by down regulation of complex I (gas-1, nuo-1, nuo-6), complex II (mev1), 
complex III (isp-1), and complex IV (cco-1) (Dingley et al., 2010; Shaye and  
Greenwald, 2011; Tsang et al., 2001) resulted in proteolytic failure in the cytosol  
(Figure 5A). Similarly, disruption of mitochondrial fission by drp-1(RNAi) 
(Labrousse et al., 1999) and mitochondrial UPR by hsp-60(RNAi) result in strong 
stabilization of the GFP-based reporter substrate (Figure 5A). In contrast, RNAi 
against hsp-4 and hsp-12.6, major chaperons involved in ER stress and heat shock 
response, respectively, had no effect, which indicates a specific crosstalk between 
mitochondrial stress response and the UPS. As shown for ivd-1 and acs-19 
depletion, the degradation defect of mitochondrial respiration mutants can be 
restored by rpn-6 overexpression or NAC treatment (Figure 3E, 4E, 5B and C). 
Moreover, treatment with antimycin A and sodium azide, two drugs known to inhibit 
respiratory complex III and IV function of  mitochondria (Chen et al., 1999; Rotsaert 
et al., 2008; Wilson and Erecinska, 1978), respectively, also resulted in strong 
stabilization of Ub-GFP (Figure 5D and E). In contrast, rotenone generating ROS 
at complex I exclusively in the mitochondrial matrix (Sena and Chandel, 2012) did 
not cause defects in UFD substrate degradation. Thus, oxidative and metabolic 
stress in mitochondria generally affect ubiquitindependent protein turnover in the 
cytosol.  
  
Reduced UPS Activity Is Linked to Human Mitochondrial Disease Pathology 
Our data strongly suggest that mitochondrial stress impairs UPS activity in C. 
elegans. Therefore, we asked whether this observation reflects a conserved link 
between mitochondrial metabolism and cellular ubiquitin-dependent proteostasis. 
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To address this question we used MelJuSo cell lines constitutively expressing the 
UFD or N-end rule substrate (Menendez-Benito et al., 2005). Whereas the 
Nterminal ubiquitin serves as degradation signal for the UFD substrate, 
deubiquitylation of N-end rule substrates defines the half-life of the remaining 
protein, which is related to the identity of its amino-terminal residue (Johnson et 
al., 1995; Varshavsky, 1992). As in worms, treatment with antimycin A resulted in 
strong stabilization of both ubiquitylated substrates (Figure 5D, E, Figure 6A, and 
Supplemental Figure S4A and S4B). In fact, this protein turnover defect can be 
restored by addition of NAC, indicating that it is based on increased ROS level 
(Figure 6B).  
Since mutations in the IVD gene, encoding the human orthologue of IVD-1 
in nematodes cause an autosomal recessive disorder called isovaleric acidemia 
(IVA), we were interested to study primary cells derived from IVA patients for 
defects in ubiquitin-dependent protein turnover. Fibroblasts from a patient with a 
severe phenotype (c.IVS4+2T>C) due to a homozygous splice site mutation 
(c.IVS4+2T>C/c.IVS4+2T>C) are lacking IVD protein completely, whereas an 
individual with a milder metabolic and clinical phenotype (c.932C>T) and 
homozygosity for a missense mutation (c.932C>T/c.932C>T) (Ensenauer et al.,  
2004) has normal IVD protein levels (Supplemental Figure S4C, Table S3). 
Western blot analysis of cell lysates showed that the overall polyubiquitin levels 
are unchanged in severe and mild IVA patient cells (Supplemental Figure S4D). 
Interestingly, transfection of the IVA fibroblasts with the N-end rule substrate 
revealed a strong stabilization of UbR-GFP especially in severe IVA patient cells 
(c.IVS4+2T>C) (Figure 6C). Moreover, the UFD substrate accumulated exclusively 
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in c.IVS4+2T>C fibroblasts as compared to control (c) or c.932C>T patient cells.  
The stabilization seen in fibroblasts with the severe IVA phenotype (c.IVS4+2T>C) 
is similar to treatment of control fibroblasts with the proteasomal inhibitor 
bortezomib (Figure 6D). These turnover defects correlate with increased ROS 
levels in the patient cells, with c.IVS4+2T>C exhibiting higher oxidative stress 
(Figure 6E). We tested whether the stabilization of the UFD and N-end rule 
substrate reflect defects in MAD. However, the levels of the OMM proteins 
mitofusin 2 (Mfn2) and Mcl1, important for mitochondrial fusion and apoptosis 
(Chan et al., 2011; Tanaka et al., 2010; Xu et al., 2011) did not increase in 
c.IVS4+2T>C patient cells (Figure 6F). Thus, in addition to the previously identified 
accumulation of metabolites (Table S3), patients suffering from IVA also display 
defects in ubiquitin-dependent protein turnover, which correlates with the degree 
of enzymatic impairment and disease pathology. Similarly, substrate degradation 
was reduced in cybrid cells from patients with a defect in the COX1 gene affecting 
respiratory complex I (G6930A) (Bruno et al., 1999; King and Attardi, 1989) 
(Supplemental Figure S4E and S4F). Thus, it appears that comparable to C. 
elegans, mitochondrial dysfunction also affects UPS activity in humans.   
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Discussion  
As defects in mitochondrial respiration are known to cause protein damage and 
mitochondrial dysfunction, the cytotoxic consequences of ROS remained 
enigmatic. With regard to human metabolic diseases it is particularly interesting 
how oxidative stress affects mitochondrial homeostasis and cellular protein quality 
control mechanisms. Here, we discovered a conserved influence of respiration 
defects and mitochondrial stress conditions on the efficiency of ubiquitin-
dependent degradation pathways in the cytosol both in C. elegans and humans. 
Acute depletion of ivd-1 and acs-19 by RNAi caused a mild but significant increase 
in ROS, which correlates with defects in UFD substrate turnover. Whereas the 
ROS levels of the originally identified ivd-1 and acs-19 mutants are comparable to 
wild-type worms or even decreased, the mutants are still limited in substrate 
degradation. This discrepancy suggests that the adaptation against an initial 
increase in ROS is not able to restore protein turnover defects, probably by long 
term changes of respiratory and metabolic processes and might support the 
manifestation of chronic disorders (Figure 4C, D, Supplemental Figure S3D). 
Consequently, besides failure in leucine and fatty acid metabolism, down 
regulation of respiratory chain function, mitochondrial fission, or mitochondrial UPR 
demonstrated a general effect of oxidative and metabolic stress on ubiquitin-
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dependent protein turnover both in C. elegans and human metabolic diseases 
(Figure 5A, D, E, and 6A, C, D, Supplemental Figure  
S4E,F).  
Surprisingly, compared to the stabilization of UFD and N-end rule 
substrates, the turnover of mitochondrial proteins via the MAD pathway remained 
unchanged from a patient with severe IVA based on homozygosity for 
c.IVS4+2T>C (Figure 6C, D, F). Thus, in contrast to MAD, protein turnover in the 
cytosol is less efficient under mild oxidative stress conditions. Accordingly, 
ROSinduced degradation defects of ivd-1 and acs-19 or antimycin A-treated 
MelJuSo cells can be suppressed by the antioxidant NAC, which does not 
compensate for loss of the MAD regulator CDC-48 (Figure 4E, Figure 6B). 
Furthermore, cdc48(RNAi) aggravates the turnover defects of ivd-1(hh6) and acs-
19(hh5) mutants thereby supporting the idea of differently affected proteolytic 
pathways (Supplemental Figure S5A and S5B). Defects in ubiquitin-dependent 
degradation caused by mitochondrial stress do not correlate with reduced viability 
of worm mutants. Conversely, the acs-19 mutant exhibits increased lifespan 
compared to wild-type worms, which can be suppressed by NAC (Figure 7A, 
Supplemental Figure S5C). This observation suggests that beneficial 
consequences of mild oxidative stress are not overruled by limited UPS function 
(Figure 7A, Table S4). Loss of HECD-1 however results in constitutively increased 
ROS level (Supplemental Figure S3D), and reduced longevity which supports the 
idea that the HECT E3 ligase provides an overlapping function both in cytosolic 
and mitochondrial protein turnover related to the role of HUWE1 (Leboucher et al., 
2012; Liu et al., 2011).  
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Conceptually, our work identified a new link between mitochondrial stress 
and UPS activity. This observation appears contradictory with regard to the 
inducible MAD pathway that degrades unfolded mitochondrial proteins in response 
to high oxidative and metabolic stress. However, specific reduction of prominent 
ubiquitin-mediated degradation pathways in the cytosol might further strengthen 
MAD by increasing the capacity of both conjugation and degradation processes at 
the mitochondrial outer membrane (Figure 7B). Indeed, overexpression of the 19S 
cap subunit rpn-6 known to trigger both the integrity and activity of the 26S 
proteasome is able to compensate cytosolic ubiquitindependent turnover defects 
(Figure 3E) (Vilchez et al., 2012a; Vilchez et al., 2012b). Thus, it is intriguing to 
speculate that mild oxidative stress conditions reinforce MAD to maintain 
mitochondrial homeostasis and cellular surveillance.    
Defects in mitochondrial metabolism are closely linked to chronic human 
diseases including cancer and neurodegeneration (Wallace, 2005). So far, 
changes in UPS function have not been specifically linked to mitochondrial 
diseases. Analyzing different human metabolic disorders, we noticed a strict 
correlation between mitochondrial failure and proteolytic defects similar to the 
observations in C. elegans (Figures 6C, D, Supplemental Figure S4E, F). 
According to our model the inhibition of cytosolic UPS pathways might contribute 
to survival on a cellular level, however, does not compensate the organismal 
consequences of the different mitochondrial defects (Figure 7B). In this regard, 
sustained maintenance of defective mitochondria could actually be the reason for 
disease pathology of otherwise harmful mutations. Patients with IVA specifically 
suffer from an accumulation of isovaleryl-CoA derivatives based on a defect in 
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isovaleryl-CoA dehydrogenase, resulting in acidification of blood and urine (Table 
S3). Early diagnosis combined with a protein restricted diet and medical therapy 
with isovaleryl-CoA conjugating agents can provide normal development even of 
severe cases (Vockley and Ensenauer, 2006). The accumulation of both UFD and 
N-end rule substrates is closely correlated with increased ROS level and the 
severity of the IVA disease pathology (Figure 6C, D, E). It is intriguing to speculate 
that changed UPS activity potentiates development and progression of metabolic 
diseases through a conserved mitochondrial surveillance response (MSR) (Figure 
7B). Thus, the response mechanisms that limit ubiquitindependent protein turnover 
provide a new target for therapeutic intervention of chronic metabolic diseases 
caused by mitochondrial failure.  
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EXPERIMENTAL PROCEDURES  
Strains  
Worms were handled according to standard procedures and grown at 15°C or 20°C 
unless otherwise stated (Brenner, 1974). Mutations and transgenes used in this 
study are listed by chromosomes as follows: cdc-48.1(tm544)II, unc119(ed4)III, 
sur-5::UbV-GFPIII, acs-19(tm4853)III, hecd-1(tm2371)IV, sur5::mCherry, sur-
5::K29,48RUb-GFP, sur-5::GFP. The Bristol strain N2 was used as wild-type and 
CB4856 Hawaii for mutant mapping studies. The strains AGD614 N2, uthEx633 
[Pmyo-3::GFP] and AGD598 N2, uthEx556 [Psur-5::rpn-6.1,Pmyo3::GFP], 
VK1879 vkEx1879 [Pnhx-2cpl-1W32AY35A::YFP;Pmyo-2mCherry], CL2166  dvIs19 
[pAF15(gst-4::GFP::NLS)] , SJ4005 zcIs4 [hsp-4::GFP]V,  SJ4100 zcIs13[hsp-
6::GFP]V , BC10060 dpy-5(e907); sEX884[hsp-70::GFP+pCeh361]    
were kind gifts from A. Dillin, C.J. Luke, C. Link, and  D. Ron, respectively.   
  
Mutagenesis  
The strain PP608 hhIs64 [unc-119(+); sur-5::UbV-GFP]III; hhIs73 [unc-119(+); sur-
5::mCherry] was grown at 15°C. 10 000 L4-staged hermaphrodites were treated 
with 50 mM EMS for 4 hr at room temperature. Worms were grown to day one of 
adulthood, bleached in sodium hypochloride solution and 86000 F1 worms 
obtained were cultured at 15°C until day one of adulthood. Worms were staged 
again by bleaching in sodium hypochlorite and the F2 population (16250 F2’s) 
analyzed with a fluorescence stereomicroscope at day one and day two of 
adulthood for stabilized Ub-GFP signal. Mutant worms were selected to new plates 
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and cultured at 15°C. For further experiments ivd-1(hh6) and acs-19(hh5) were 
outcrossed six times against wild-type worms.  
  
Mutant identification  
Mutants obtained by EMS mutagenesis were analyzed for chromosome linkage  
(ivd-1, acs-19 and hecd-1) and interval mapping (ivd-1, acs-19) according to Davis 
et al. (Davis et al., 2005). Here, mutant worms were crossed with CB4856 and Ub-
GFP stabilization served as marker for the mutant phenotype. The mutants were 
sequenced by whole genome sequencing as described recently (Doitsidou et al., 
2010; Sarin et al., 2008). For acs-19 and ivd-1 the mutations were verified after six 
times outcrossing against wild-type worms, selection of mutant phenotype and 
Sanger sequencing of the mutation.  
  
RNAi  
RNA interference was performed using the feeding method (Segref and Hoppe, 
2012). Typically, worms were treated with RNAi from L1 stage and the phenotype 
observed during day one of adulthood unless otherwise stated. For ivd-1, acs-19, 
and hecd-1 RNAi, stabilization of Ub-GFP served as an internal control for RNAi 
efficiency.  
  
Generation of transgenic C. elegans  
The original mutant strains obtained after EMS mutagenesis were injected with  
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10 ng/ L of the fosmids (WRM0620aH08 (for acs-19) or WRM061bH04 (for ivd1), 
and 100 ng/ L of pRF4 (rol-6(su1006dm)). Rescued F1 animals were analyzed at 
day one of adulthood for expression of GFP.  
  
In vivo imaging  
In vivo imaging was performed as described recently (Segref and Hoppe, 2012).  
  
Immunoblotting  
Worms were lyzed in SDS sample buffer and equal volumes applied to SDSPAGE 
as described recently (Segref and Hoppe, 2012). Western blotting was performed 
using antibodies against GFP (Clontech), ubiquitin (Upstate), mCherry  
(Abcam), tubulin (Sigma), and IVD (R. Ensenauer).  
  
Polyubiquitylation  
To investigate the polyubiquitylation status, worms were grown at 20°C till day one 
of adulthood. Worms were washed off the plates with 1x M9 buffer, settled on ice 
and the worm pellet lyzed in SDS sample buffer containing 10 mM NEM at 95°C 
for 4 minutes. Worms were analyzed by western blotting using an antibody against 
ubiquitin and tubulin as loading control. For polyubiquitylation of tissue culture 
cells, cells grown at similar densities were collected in SDS sample buffer and 
subjected to western blotting.  
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Quantification of ROS in Nematodes by MitoTracker Red Fluorescence 
Nematodes were synchronized and either grown to day 1 adult stage or L1 larvae 
and treated with RNAi against, ivd-1, acs-19, or the empty control vector for 48 hrs. 
Worms were washed off the plates with S-basal buffer (pH 6) and allowed to settle 
by centrifugation (200 x g, 1 min). The worm pellet was transferred to plates 
spotted with 500 µl heat-inactivated OP50 (65°C, 30 min) mixed with 100 µl 
MitoTracker Red CM-H2X stock solution (100 M; freshly prepared) for 2 h at 20°C. 
To remove excess dye from the gut, the nematodes were washed with S-basal 
buffer 3 times and transferred to new plates with either OP50 or RNAi for 1 h at 
20°C. 100 µl worm suspension aliquots in S-basal buffer were distributed into 8 
wells/condition of a 96-well FLUOTRACTM plate (Greiner Bio-One,). Fluorescence 
(ex: 570 nm, em: 610 nm) was measured in a plate reader (FLUOstar Optima, 
BMG Labtech,). To normalize the fluorescence signal, the protein content in the 
remaining worm suspension was determined using the Bradford assay.   
  
Quantification of Hydrogen Peroxide Production of Nematodes by 
AmplexRed Fluorescence  
Worms were treated with RNAi against ivd-1, acs-19 or control vector with and 
without NAC (final 10 mM) for 48 h beginning at L1 stage. As internal positive 
control we incubated one part of the control worms on plates containing antimycin 
A (final 1 µM) for 2h right before the measurement. Worms were removed from 
plates with sodium-phosphate buffer (50 mM, pH 7.4) and washed twice. Ampliflu 
(Sigma-Aldrich) solution (final concentration 10 µM) and horseradish peroxidase 
(Sigma-Aldrich, final concentration 10 mU/ml) were added to the nematodes. 
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Measurement was carried out in 96-well Fluotrac plates (Bio Greiner One) using a 
micro plate reader (FLUOstar Optima, BMG Labtech) and filters for excitation at 
544 nm and emission at 590 nm for  20 min at 20 °C.   
  
Measurement of mitochondrial ROS in primary human fibroblasts  
Primary human fibroblast cells were incubated with 5 M MitoSOX Red (Molecular 
Probes®) for 30 minutes and ROS levels determined by imaging the cells with a 
Zeiss Meta 510 Confocal Laser Scanning Microscope (Abs.: 514 nm/Em.: 561 nm). 
Fluorescent images of MitoSOX-stained cells were taken with a 20x objective. 
Images were processed with ImageJ 1.48e software and mean fluorescence 
intensities of single cells are shown on the graph.  
  
Stress tests  
NGM plates containing 3 M rotenone (Sigma, 100 mM stock in DMSO), 2 M 
antimycin A (Sigma,10 mM stock in 100% ethanol), or 0.2 mM sodium azide 
(Sigma, 200 mM stock in water, (only DMSO, ethanol or water was added to the 
respective control plates) were prepared freshly before the start of the experiment. 
The strain PP563 hhIs64 [unc-119(+); sur-5::UbV-GFP]III was grown from L4 stage 
for 12 h at 20°C and analyzed for expression of Ub-GFP by microscopy and 
western blotting. To analyze development, staged young adult worms were placed 
on NGM plates with ethanol as control or with 2 M antimycin A and allowed to lay 
eggs for four hours. The adult worms were removed from the plates and the 
offspring grown at 15°C for 5 days. Worms were examined for their developmental 
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stage and grouped into adult worms or worms that had reached only a larval stage. 
For treatment with antioxidants, NGM plates containing N-acetyl cysteine (Sigma) 
(500 mM stock in water) were prepared freshly. L1-staged mutants worms 
expressing sur-5::UbV-GFP were added to the plates and grown at 15°C till day 
one of adulthood. Worms were collected in SDS sample buffer and analyzed by 
western blotting for expression of Ub-GFP.  
  
ATP Measurements  
200 day 1 adult hermaphrodite worms grown at 15°C were collected, washed 4 
times in 1x M9 buffer, and frozen at -80°C before extract preparation. ATP levels 
were measured using the ATP bioluminescence kit HSII (Roche) according to the 
manufacturer’s instruction. In brief, worms were lyzed in 500 l lysis buffer 
provided with the kit, kept on ice for 10 min with brief vortexing every 2 min. The 
lysate was incubated at 95°C for 5 min, sonicated with a microsonicator and 
incubated at 95°C for 5 min. The lysates were centrifuged at 13000 rpm for 2 min 
at room temperature. 50 l of the lysate was mixed with 50 l of the Luminescence 
reagent provided with the kit using the Tecan infinite 200 microplate reader. 
Analysis was performed with a readout time of 10 s. An ATP curve in the extract 
was performed to ensure linearity of the measurement.   
  
Proteasome activity  
Proteasome activity was measured essentially as described previously (Vilchez et 
al., 2012b).   
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Lifespan analysis  
Lifespan analysis was performed as described recently (Kuhlbrodt et al., 2011).  
  
Cell culture and transfections  
WT and G6930A cells were cultivated in DMEM with Glutamax supplemented with 
5% FCS, 50 g/ml Uridine, 1 mM sodium pyruvate, 100 g/ml Streptomycin, and 
100 U/ml Penicillin at 37°C and 5% CO2. Primary human IVD fibroblast cell lines 
were derived from skin of two children with isovaleric acidemia diagnosed by a 
disease-related metabolic pattern and homozygous IVD gene mutations, and of a 
healthy child undergoing inguinal hernia repair that served as a control cell line, 
after informed consent was obtained (Table S3). MelJuSo cells were cultivated in 
DMEM and fibroblasts in DMEM with Glutamax supplemented with  
10% FCS, 100 g/ml Streptomycin, and 100 U/ml Penicillin at 37°C and 5% CO2.  
Transfection was performed in 6 cm dishes using 10 g of UbG76V-GFP or 
UbRGFP (Dantuma et al., 2000) obtained from N. Dantuma and 5 g pmCherry-
C1 with 10 L Lipofectamine 2000 (Life Technologies) according to the 
manufacturers instruction. Cells were collected in SDS sample buffer after 24 h 
and analyzed by SDS-PAGE and western blotting. In case of Bortezomib 
treatment, 20 nM Bortezomib or as control DMSO was added to the culture 6 h  
after transfection.   
  
Statistics  
The mean +/- s.d. is reported unless otherwise indicated. Statistical comparisons 
among groups were determined using two-tailed Student’s t test with a  
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significance value of p ≤ 0.05.    
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FIGURE LEGENDS  
  
Figure 1. A mutagenesis screen to identify novel genes involved in UPS-mediated 
protein turnover.  
A) Outline of the mutagenesis screen performed on hermaphrodite worms expressing the 
UPS reporter Psur-5::UbV-GFP. B) Fluorescence and Nomarski images of worms 
expressing Ub-GFP in wild-type (WT) or hecd-1 mutant worms as indicated. Scale bar: 
100 m. C) Protein lysates of worms displayed in (B), including one additional allele hecd-
1(hh9), were analyzed by SDS-PAGE and immunoblotting against GFP and  
tubulin as loading control.  
  
Figure 2. Novel mutations in ivd-1 and acs-19 display defects in Ub-GFP turnover.  
A) Fluorescence and Nomarski images of wild-type (WT) or ivd-1(hh6) mutant worms and 
of wild-type worms grown on control (RNAi) (ctrl (RNAi)) or ivd-1(RNAi) plates analyzed 
for stabilization of Ub-GFP at day 1 of adulthood. Scale bar: 100 m. B) As in (A) but acs-
19(hh5) worms were compared to WT and acs-19(RNAi). Scale bar: 100 m. C) Western 
blot analysis of protein lysates derived from day 1 adult worms expressing Ub-GFP as 
indicated. The blot was probed against GFP and tubulin as loading control. D) 
Fluorescence and Nomarski images of worms expressing Ub-GFP in ivd-1(hh6) mutants 
with or without the ivd-1 gene-containing fosmid WRM061bH04 (ivd1(hh6)+ivd-1). 
Bottom: acs-19(hh5) mutants without (acs-19(hh5)) or with the acs-19 gene-containing 
fosmid WRM0620aH08 (acs-19(hh5)+ acs-19). Fluorescent images were taken with the 
same exposure times. Scale bars: 100 m. E) Lysates of day 1 adult worms expressing 
Ub-GFP  treated with RNAi against  the C. elegans orthologues of human branched chain 
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keto acid dehydrogenase E1 (tag-173) and alpha methylcrotonyl coenzyme A 
carboxylase 1 (mccc-1) involved in leucine catabolism were analyzed by western blotting 
against GFP and tubulin. F) Worms expressing Ub-GFP were depleted by RNAi for the 
indicated genes and analyzed by western blotting as in (C).  
  
Figure 3. Protein turnover in ivd-1, acs-19, or hecd-1 worms.  
A) Worms expressing either CPL-1W32A, Y35A-YFP (CPL-1W32A, Y35A) or Ub-GFP (UbVGFP) 
were RNAi-treated as indicated and lysates of worms analyzed by western blotting with 
an antibody against GFP that also recognizes YFP (anti-GFP) and tubulin. B) Lysates of 
day 1 adult mutant worms were analyzed for the presence of  
polyubiquitylated substrates by western blotting against polyubiquitin. As a control 
cdc48.1(tm544) mutants were either treated with control (RNAi) or cdc-48.2 (RNAi). C) 
Relative ATP levels in day 1 old wild-type (WT) and mutant worms. Results display three 
(ivd-1, hecd-1), five (WT) and four independent experiments (acs-19), average +/- s.d. ** 
p ≤ 0.01. D) Relative slopes of chymotrypsin, trypsin, and caspase-like proteasomal 
activity of day 1 old wild-type (WT) and mutant worms. Averages are displayed of 5 to 7 
independent experiments +/- s.e.m, p>0.05.  E) Hermaphrodites expressing either GFP 
(GFP(OE)) or rpn-6.1 and GFP (rpn-6.1,GFP(OE)) on extrachromosomal arrays and 
integrated sur-5::UbV-GFP were RNAi-treated and lysates examined by western blotting 
as in (2C).  
  
Figure 4. Cellular stress response by disruption of ivd-1, acs-19, or hecd-1 
function.  
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A) Hermaphrodites expressing sur-5::UbV-GFP or sur-5::GFP were RNAi-treated against 
the indicated genes and lysates of day 1 adult worms subjected to western blotting 
against GFP and tubulin. B) Hermaphrodites were RNAi-treated against the indicated 
genes and analyzed for the expression of gst-4::GFP at day 1 adult stage. Western 
blotting was performed as in (2C). C) ROS levels of WT hermaphrodites (expressing sur-
5::UbV-GFP as control for RNAi efficiency) that were treated with the indicated RNAi’s for 
48 h (control, acs-19, ivd-1). Data are averages derived from 2 independent experiments 
+/- s.e.m,  ***p ≤ 0.001. D) H2O2 production measured by Amplex Red staining of the 
strain used in (C) treated with RNAi as indicated or antimycin A with or without N-acetyl 
cysteine (NAC). Averages from 2 independent experiments +/- s.e.m., p values: *** p ≤ 
0.001, * p ≤ 0.05, (-) NAC compared to the control, (+) NAC were compared to the (–) 
NAC counterpart to indicate significant suppression by NAC. E) Mutant worms expressing 
sur-5::UbV-GFP were grown on control plates (c), or plates containing 10 mM NAC from 
L1 stage to day 1 of adulthood. Western blotting was performed as in (2C), short exp., 
long exp: short and long exposure of the blot, respectively.  
  
Figure 5. Disruption of mitochondrial function impairs Ub-GFP turnover.  
A) Wild-type worms expressing sur-5::UbV-GFP were treated with the indicated RNAi’s 
and lysates of worms examined by western blotting as in (2C). B) Hermaphrodites 
expressing either GFP (-) (GFP(OE)) or rpn-6.1 and GFP (+) (rpn-6.1,GFP(OE)) on 
extrachromosomal arrays and integrated sur-5::UbV-GFP were RNAi-treated and lysates 
examined by western blotting as in (2C). C) Wild-type worms expressing sur5::UbV-GFP 
were treated with the indicated RNAi’s from L1 to adulthood and moved to control (-) or 
10 mM NAC-containing NGM plates (+) 24 hr prior to collection. Lysates of worms were 
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examined by western blotting as in (2C). D) Fluorescence and Nomarski images of wild-
type worms expressing Ub-GFP either untreated (control), or treated with  
3 M rotenone, 2 M antimycin A, or 0.2 mM sodium azide (NaN3) for 12 h. Scale bar:  
1 mm. (E) Lysates of worms displayed in (D) were analyzed by western blotting against 
GFP and tubulin.   
  
Figure 6. Disease-related mitochondrial mutations disrupt UPS-mediated protein 
turnover in humans.  
A) MelJuSo cell lines stably expressing UbR-YFP or UbG76V-YFP were pre-treated for  
18 hours with ethanol as control (-) or 100 M antimycin A (in ethanol) followed by  100 
g/ml cycloheximide for the indicated time points. Cell lysates were analyzed by western 
blotting against YFP and tubulin. B) Cell lines from (A) were pretreated with H2O (-) or the 
indicated concentrations of N-acetylcysteine (NAC), followed by 18 hrs incubation with 
100 M antimycin A with or without NAC. Cell lysates were analyzed as in (A). C, D) 
Primary human control fibroblasts (c) and fibroblasts from IVD-deficient patients with a 
severe (c.IVS4+2T>C) or mild (c.932C>T) phenotype were transfected with UbR-GFP or 
UbG76V-GFP and mCherry as transfection control and cell lysates were analyzed by 
western blotting against GFP, mCherry and tubulin. E) Mitochondrial  
ROS content was measured in fibroblast cells described in (C) using MitoSOX staining.  
Mean fluorescence intensities normalized to the average fluorescence measured in the 
control cell line are shown with the s.e.m. (c: 1.00 +/- 0.04; c.IVS4+2T>C: 1.59 +/- 0.06  
(***p ≤ 0.001); c.932C>T: 1.16 +/- 0.06 (*p ≤ 0.05)); (nc = 166; nc.IVS4+2T>C = 139; nc.932C>T = 
132). F) Untransfected fibroblast cell lines as described in (C) were analyzed by western 
blotting with antibodies against Mfn2, Mcl1, and tubulin.  
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Figure 7. ROS-induced attenuation of ubiquitin-dependent proteolysis in the 
cytosol supports cellular surveillance.  
A)  Lifespan analysis of worms as indicated grown at 20°C on NGM containing OP50. 
Detailed statistics are provided in Table S4. B) Damaged mitochondrial proteins 
accumulating upon high ROS levels are degraded via the recently identified MAD 
pathway. This process involves the stress induced recruitment of the ubiquitin-selective 
chaperone Cdc48 to the outer mitochondrial membrane, which facilitates the 
retrotranslocation and targeting of mitochondrial proteins to the UPS machinery. In 
contrast, low levels of ROS reduce the activity of cytosolic protein degradation pathways 
(UFD and N-end rule pathway), which might further strengthen MAD by increasing the 
capacity of both conjugation and degradation processes at the mitochondrial outer 
membrane. Thus, the general effect of low oxidative stress on the UPS reflects a 
conserved mitochondrial surveillance response (MSR).   
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Supplemental Figure 1  
Schematic outline of the hecd-1, acs-19 and ivd-1 mutations identified. A) Outline of the 
identified hecd-1(hh2) –(hh4) alleles as resolved by whole genome sequencing. B) Using 
SNP analysis, the acs-19 mutation was mapped to a 3.96 Mbp region between the SNPs 
CE3-127 (physical location 3359035) and snp_F56C9 (physical location 7320107) (Davis 
et al., 2005) on chromosome III. C) The ivd-1 mutation was mapped to a 3.6 Mbp region 
between the SNPs pKP4064 (physical location 4285309) and pKP4077 (physical location 
7900254) on chromosome IV. D) C. elegans IVD-1 (AAD21088.1) was aligned with 
Drosophila  CG6638-PA  (AAF50398.1), Homo sapiens IVD (AAA52711.1) and 
Arabidopsis IVD (AEE78020.1) using the Clustal W2 multiple sequence alignment 
program and further processed using the Jalview multiple alignment editor. In brackets 
are the GenBank accession numbers. The blue colour denotes percentage identity. The 
missing residues in the IVD-1 mutant identified in this work are indicated with stars. E) 
ACS-19 from C. elegans (CAA91274.1) was aligned with Homo sapiens ACSS2 
(AAH98422.1), Drosophila ACS (AAF51695.2) and S. cerevisiae Acs1p (AAC04979.1). In 
brackets are the GenBank accession numbers. Blue color denotes the percentage 
identity. The mutation site in C. elegans ACS-19 identified in this work is indicated by a 
star.  
  
  
Supplemental Figure 2  
Chromosomal rescue of ivd-1(hh6) and acs-19(hh5).  A) ivd-1(hh6) mutants without or 
after extrachromosomal expression of the ivd-1 gene present on the fosmid 
  
WRM061bH04 (ivd-1(hh6)+ivd-1). After injection of the fosmid 60.1% (+/- 28.4 s.d, n=38, 
4 independently injected lines) of the worms carrying the extrachromosomal array showed 
no GFP fluorescence, indicating suppression of the Ub-GFP stabilization, as compared 
to 3.5% (+/-1.1 s.d, n=327,** p ≤ 0.01) of the worms that did not carry the array. B) acs-
19(hh5) mutants without (acs-19(hh5)) or after chromosomal expression of the acs-19 
gene present on fosmid WRM0620aH08 (acs-19(hh5) +acs-19). After fosmid injection 
57.0% (+/-9.3 s.d, n=279, 2 independently injected lines) of the worms carrying the 
extrachromosomal array showed no GFP expression whereas 19.1% (+/- 8.0 s.d, *** p ≤ 
0.001) not carrying the array were GFP-negative. C) acs-19(hh5) mutants without (acs-
19 (-)) or after chromosomal expression of the acs-19 gene present on fosmid 
WRM0620aH08 (acs-19(+) were analyzed at day one of adulthood. Injection 1 and 2 
denote two independent strains obtained after injection. Worms were collected in SDS 
sample buffer and extracts analyzed by western blotting against GFP and tubulin. D) 
Worms expressing K29,48R-Ub-GFP or GFP were depleted by RNAi for the indicated genes 
and analyzed by western blotting against GFP and tubulin. E) Fluorescence and 
Nomarski images of day 1 adult worms expressing UbV-GFP  treated with RNAi against  
the C. elegans orthologs of human Branched chain keto acid dehydrogenase E1 (tag173) 
and alpha methylcrotonyl coenzyme A carboxylase 1 (mccc-1) involved in leucine 
catabolism.  
  
Supplemental Figure 3   
Stress response and protein turnover after RNAi. A) RNAi-treated hermaphrodites were 
analyzed for the expression of hsp-4::GFP at day 1 adulthood. Western blot of lysates 
  
were probed against GFP and tubulin. B) Worms expressing hsp-70::GFP were treated 
with RNAi  till day 1 of adulthood at 20°C or on NGM seeded with OP50 at 20°C (control 
20°C). For heat shock day 1 old worms were placed at 35°C for 30 min and allowed to 
recover at 20°C for 4 hr. Extracts of worms were analyzed by western blotting as in (A). 
C) RNAi-treated hermaphrodites were analyzed for the expression of hsp-6::GFP at day 
1 adulthood as in (A).  D) ROS levels of the indicated strains were measured in day 1 
adult hermaphrodites. Data display averages of 3 to 4 independent experiments +/- 
s.e.m., ***p ≤ 0.001. E) Worm development on control or 2 M antimycin A-containing 
plates. A (Adults), L (Larvae), data display the averages of three experiments +/- s.d., *p 
≤ 0.05, **p ≤ 0.01.  
Supplemental Figure 4  
Analysis of tissue culture and patient cells.  A) MelJuSo cell lines stably expressing  
UbR-YFP were pre-treated for 18 hours with ethanol as control (-) or 100 M antimycin A 
(in ethanol) followed by  100 g/ml cycloheximide for the indicated time points. Cell 
lysates were analyzed by western blotting against YFP as shown in Figure 6, but. a strong 
exposure is presented to highlight the polyubiquitylated substrate. B) Similar to  
(A) but MelJuSo cells stably expressing UbG76V-YFP from Figure 6 A are displayed. C) 
Primary human control fibroblasts (c), and fibroblasts from IVD-deficient patients with 
severe (c.IVS4+2T>C) or mild phenotypes (c932C>T) were examined for the levels of 
IVD by western blotting. D) Lysates of cell lines from (C) were analyzed by western 
blotting against ubiquitin and tubulin. E) Cybrid cells containing the G6930A mutation in 
the COX1 gene (G6930A) (Bruno et al., 1999)  compared to the corresponding wild-type 
cells (WT) were transfected with UbR-GFP and mCherry as transfection control. Cell 
  
lysates were analyzed by western blotting against GFP, mCherry, and tubulin. F) same 
as (E), but cells were transfected with UbG76V-GFP. We observed an accumulation of a 
cleavage product (indicated by a star), similar to the cleavage product reported previously 
for tissue culture cells after proteasomal inhibition (Dantuma et al., 2000). This seems to 
reflect increased hydrolytic processing of the stabilized UbG76V-GFP in these cells.  
Supplemental Figure 5   
Cellular surveillance in ivd-1(hh6), acs-19(hh5) and hecd-1(tm2371) mutants.  
A) Wild type (WT) or mutant hermaphrodites expressing sur-5::UbV-GFP were treated 
with control or cdc-48(RNAi) as indicated and analyzed by fluorescence microscopy. 
Scale bar: 1 mm. B) Lysates of worms shown in panel (A) were examined by western 
blotting with anti-GFP and anti-tubulin antibodies. C) Lifespan analysis of worms as 
indicated grown from L1 stage at 20°C on NGM or NGM containing 10 mM N- 
acetylcysteine (NAC) seeded with OP50. Detailed statistics are provided in Table S5.  
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Mutant  Development   Tissue   
 L  A  P  I  V  T  
hecd-1 
(hh2)  +  +  +  +  +  +  
hecd-1 
(hh3)  +  +  +  +  +  +  
hecd-1 
(hh4)  +  +  +  +  +  +  
acs-19 
(hh5)  +  +  -  +  -  -  
ivd-1  
(hh6)  +  +  -  +  -  -  
hecd-1 
(hh9)  +  +  +  +  +  +  
  
Table S1. Stabilisation of Ub-GFP in mutants identified. L: during larval stage, A: during adult 
stage, P: pharynx, I: intestine, V: vulva, T: tail.  
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 Mutants  
hecd-1 
(hh2)  
hecd-1 
(hh3)  
hecd-1 
(hh4)  
ivd-1 
(hh6)  
hecd-1 
(hh9)  
acs-19 
(hh5)  
hecd-1(hh2)  
  -  -  +  -    
hecd-1(hh3)      -  +  -    
hecd-1(hh4)        +  -    
hecd-1(tm2371)  -  -    +      
ivd-1(hh6)          +    
acs-19(tm4853)  
          -  
eel-1(ok1575)        +      
ubc-1(gk14)        +      
uba-1(it129)     +    
  
Table S2. Non-complementation tests to assign mutant complementation groups. Plus  
(+): mutants are complementing each other, minus(-): mutants are non-complementing.  
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Primary 
human  
fibroblasts  
IVD gene 
mutations  
Metabolite  
  
Blood  
isovalerylcarnitine  
accumulation  
Urine  
isovalerylglycine  
  
Clinical 
presentation  
IVA severe   
  
c.IVS4+2T>C/   
c.IVS4+2T>C  
15 µM  1400 mmol/mol 
creatinine  
Diagnosed 
during 
neonatal 
metabolic  
crisis, 
learning 
disability  
IVA mild  
  
c.932C>T 
(p.A282V)/ 
c.932C>T 
(p.A282V)  
1.4 µM  30 mmol/mol 
creatinine  
Diagnosed by 
metabolic 
newborn 
screening, 
asymptomatic  
  
Table S3. Cellular genotype, metabolite pattern and clinical phenotype of individuals 
with severe and mild isovaleric acidemia. IVA: isovaleric acidemia, IVD: 
isovalerylCoA dehydrogenase.   
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Experiment 1  mean  Stdv  n  SEM  p-value  (t-test)  p-value 
(Mantel-Cox)  
WT  13.45  6.8  33  1.2      
acs-19(hh5)  14.44  9.1  36  1.5  WT     0.394 acs-19(tm4853) 
0.125  
0.214  
0.624  
acs-19(tm4853)  17.87  6.6  47  1.0  WT    < 0.01  <0.05  
ivd-1(hh6)  14.2  6.7  35  1.1  WT      0.911  0.635  
          acs-19(hh5) 0.68  0.290  
          acs-19(tm4853) <0.01  <0.05  
Experiment 2              
WT  12.89  6.6  36  1.1      
acs-19(hh5)  16.12  7.9  33  1.4  WT <0.001 acs-19(tm4853) 
<0.001  
<0.05  
0.830  
acs-19(tm4853)  16.68  6.3  44  0.9  WT <0.001  <0.05  
ivd-1(hh6)  16.48  7.5  29  1.4  WT <0.001  <0.05  
          acs-19(hh5) <0.001  0.824  
          acs-19(tm4853) <0.001  0.703  
Experiment 3              
WT  13.73  7.7  30  1.4      
acs-19(hh5)  18.78  7.0  36  1.2  WT <0.001 acs-19(tm4853) 
< 0.001  
<0.05  
0.055  
acs-19(tm4853)  15.62  7.3  42  1.1  WT <0.01  0.499  
ivd-1(hh6)  14.76  7.8  37  1.3  WT <0.001  0.611  
          acs-19(hh5) <0.001  0.110  
          acs-19(tm4853) 0.206  0.905  
Experiment 4              
WT  13.51  6.6  37  1.1      
acs-19(hh5)  16.98  6.8  42  1.1  WT <0.001 acs-19(tm4853) 
0.07  
<0.05  
0.536  
acs-19(tm4853)  17.26  7.7  46  1.1  WT <0.001  <0.01  
ivd-1(hh6)  15.43  7.2  40  1.1  WT <0.001  0.139  
          acs-19(hh5) <0.001  0.452  
          acs-19(tm4853) 0.11  0.215  
All combined              
WT  
acs-19(hh5)  
13.38  
16.61  
6.8  
7.8  
136  
147  
0.6  
0.6  
  
WT <0.001 acs-19(tm4853) 
0.724  
  
<0.001  
0.528  
acs-19(tm4853)  16.89  7.0  179  0.5  WT <0.001  <0.001  
ivd-1(hh6)  15.16  7.3  141  0.6  WT 0.036  <0.05  
          acs-19(hh5) 0.066  0.067  
          acs-19(tm4853) 0.344  0.123  
Table S4 Statistical analysis of wild-type (WT), ivd-1(hh6), acs-19(hh5) and acs-19(tm4853) 
grown on OP50. n= number of animals.  
  
 
Experiment 1  mean  Stdv  n  SEM  p-value  (t-test)  p-value (Mantel-
Cox)  
WT  12.42  5.7  31  1.0      
acs-19(tm4853)  16.11  6.1  45  0.9  WT                0.222 ivd-
1(hh5)     0.294  
<0.01  
<0.05  
ivd-1(hh6)  12.03  5.7  29  1.1  WT                0.170  0.856  
WT + NAC  6.17  1.8  24  0.4  WT              <0.001  <0.001  
acs-19(tm4853)+ 
NAC  
7.92  3.0  38  0.5  WT              <0.001 WT 
+ NAC    0.166 acs-
19(tm4853) <0.001  
<0.001  
<0.01  
<0.001  
ivd-1(hh6)+ NAC  5.47  2.6  17  0.6  WT              <0.001 WT 
+ NAC     0.509 ivd-
1(hh6)    <0.001  
<0.001  
0.307  
<0.001  
Experiment 2              
WT  10.97  5.9  32  1.1      
acs-19(tm4853)  15.61  6.0  44  0.9  WT               <0.001 ivd-
1(hh5)    <0.001  
<0.01  
<0.01  
ivd-1(hh6)  11.06  5.1  31  0.9  WT               <0.01  0.917  
WT + NAC  6.49  2.6  23  0.5  WT               <0.01  <0.01  
acs-19(tm4853)+ 
NAC  
7.19  2.6  42  0.4  WT               <0.001 WT 
+ NAC    <0.05 acs-
19(tm4853) <0.001  
<0.001  
0.339  
<0.001  
ivd-1(hh6)+ NAC  6.43  3.0  21  0.7  WT                  <0.001 WT 
+ NAC       0.131 ivd-
1(hh6)      <0.001  
<0.001  
0.798  
<0.001  
Experiment 3              
WT  11.51  5.4  35  0.9      
acs-19(tm4853)  16.19  6.8  42  1.0  WT                 <0.001 ivd-
1(hh5)       <0.01  
<0.001  
0.101  
ivd-1(hh6)  13.00  6.3  24  1.3  WT                 <0.001  0.305  
WT + NAC  6.00  3.2  25  0.6  WT                 <0.001  <0.001  
acs-19(tm4853)+ 
NAC  
7.46  2.8  37  0.5  WT                 <0.001 WT 
+ NAC       0.798 acs-
19(tm4853) <0.001  
<0.001  
0.068  
<0.001  
ivd-1(hh6)+ NAC  7.08  5.3  25  1.1  WT                  <0.01 WT 
+ NAC       0.064 ivd-
1(hh6)       <0.001  
<0.01  
0.712  
<0.001  
Experiment 4              
WT  12.07  6.4  27  1.2      
acs-19(tm4853)  16.18  6.4  49  0.9  WT                   0.278 ivd-
1(hh5)        0.068  
<0.05  
<0.05  
ivd-1(hh6)  12.37  5.6  27  1.1  WT                   0.362  0.975  
WT + NAC  6.08  2.3  25  0.5  WT                 <0.001  <0.001  
acs-19(tm4853)+ 
NAC  
8.27  4.5  41  0.7  WT                 <0.001 WT 
+ NAC        0.050 acs-
19(tm4853) <0.001  
<0.01  
<0.01  
<0.001  
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ivd-1(hh6)+ NAC  6.25  3.4  24  0.7  WT                   <0.001 WT 
+ NAC         0.233 ivd-
1(hh6)        <0.001  
<0.001  
0.861  
<0.001  
  
  
Table S5 Statistical analysis of wild-type (WT), ivd-1(hh6), and acs-19(tm4853) mutants on 
NGM plates or NGM plates containing 10 mM NAC (+NAC) seeded with OP50. n= number of 
animals.  
All combined              
WT  
acs-19(tm4853)  
11.72  
16.03  
5.8  
6.3  
125  
180  
0.5  
0.5  
  
WT               <0.001 ivd-
1(hh5)    <0.001  
  
<0.001  
<0.001  
ivd-1(hh6)  12.05  5.6  111  0.5  WT                0.120  0.715  
WT + NAC  6.18  2.5  97  0.3  WT               <0.001  <0.001  
acs-19(tm4853)+ 
NAC  
7.71  3.3  158  0.3  WT               <0.001 WT 
+ NAC     0.05 acs-
19(tm4853) <0.001  
<0.001  
<0.001  
<0.001  
ivd-1(hh6)+ NAC  6.38  3.8  87  0.4  WT               <0.001 WT 
+ NAC    0.39 ivd-
1(hh6)     <0.001   
<0.001  
0.964  
<0.001  
